Proportion of innovative drug revenue exceeds 60% for the first time, Hengrui Pharma reports Q1 revenue of 8.1 billion yuan, net profit up 22% year-on-year|Financial Report News
April 22, Hengrui Medicine released its quarterly report. During the reporting period, the company achieved operating income of 8.141 billion RMB, an increase of 12.98% year-on-year; net profit attributable to shareholders of 2.282 billion RMB, a year-on-year increase of 21.78%, with profit growing faster than revenue;